96 related articles for article (PubMed ID: 16040397)
1. Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells.
Fehm T; Solomayer EF; Meng S; Tucker T; Lane N; Wang J; Gebauer G
Cytotherapy; 2005; 7(2):171-85. PubMed ID: 16040397
[TBL] [Abstract][Full Text] [Related]
2. Characterization of circulating tumor cells by fluorescence in situ hybridization.
Swennenhuis JF; Tibbe AG; Levink R; Sipkema RC; Terstappen LW
Cytometry A; 2009 Jun; 75(6):520-7. PubMed ID: 19291800
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
Fehm T; Sagalowsky A; Clifford E; Beitsch P; Saboorian H; Euhus D; Meng S; Morrison L; Tucker T; Lane N; Ghadimi BM; Heselmeyer-Haddad K; Ried T; Rao C; Uhr J
Clin Cancer Res; 2002 Jul; 8(7):2073-84. PubMed ID: 12114406
[TBL] [Abstract][Full Text] [Related]
4. Correspondence re: T. Fehm et al., Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res., 8: 2073-2084, 2002.
Fiegl M; Kircher B; Zojer N
Clin Cancer Res; 2003 Mar; 9(3):1224-5; author reply 1226. PubMed ID: 12631629
[No Abstract] [Full Text] [Related]
5. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
[TBL] [Abstract][Full Text] [Related]
6. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor cells (CTC) detection: clinical impact and future directions.
Paterlini-Brechot P; Benali NL
Cancer Lett; 2007 Aug; 253(2):180-204. PubMed ID: 17314005
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
9. Nonrandom chromosomal numerical abnormality as a new molecular cytogenetic tumor marker--a retrospective study of 60 gastric cancer cases.
Kitayama Y; Sugimura H
Rinsho Byori; 2005 Oct; 53(10):881-6. PubMed ID: 16296333
[TBL] [Abstract][Full Text] [Related]
10. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
[TBL] [Abstract][Full Text] [Related]
11. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
Zheng S; Lin H; Liu JQ; Balic M; Datar R; Cote RJ; Tai YC
J Chromatogr A; 2007 Aug; 1162(2):154-61. PubMed ID: 17561026
[TBL] [Abstract][Full Text] [Related]
12. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-expressing viruses allow rapid identification and separation of rare tumor cells in spiked samples of human whole blood.
Fong SM; Lee MK; Adusumilli PS; Kelly KJ
Surgery; 2009 Sep; 146(3):498-505. PubMed ID: 19715807
[TBL] [Abstract][Full Text] [Related]
14. AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
Giltnane JM; Murren JR; Rimm DL; King BL
Histopathology; 2006 Aug; 49(2):161-9. PubMed ID: 16879393
[TBL] [Abstract][Full Text] [Related]
15. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
[TBL] [Abstract][Full Text] [Related]
16. Bright-field in situ hybridization for HER2 gene amplification in breast cancer using tissue microarrays: correlation between chromogenic (CISH) and automated silver-enhanced (SISH) methods with patient outcome.
Francis GD; Jones MA; Beadle GF; Stein SR
Diagn Mol Pathol; 2009 Jun; 18(2):88-95. PubMed ID: 19430296
[TBL] [Abstract][Full Text] [Related]
17. Molecular signature detection of circulating tumor cells using a panel of selected genes.
Gervasoni A; Monasterio Muñoz RM; Wengler GS; Rizzi A; Zaniboni A; Parolini O
Cancer Lett; 2008 May; 263(2):267-79. PubMed ID: 18262345
[TBL] [Abstract][Full Text] [Related]
18. [FISH analysis in the differential diagnosis of flat urothelial lesions using tissue microarrays].
Schwarz S; Rechenmacher M; Lottner C; Brockhoff G; Hartmann A; Langer S; Knüchel R
Verh Dtsch Ges Pathol; 2004; 88():184-93. PubMed ID: 16892551
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells and bone marrow micrometastasis.
Alix-Panabières C; Riethdorf S; Pantel K
Clin Cancer Res; 2008 Aug; 14(16):5013-21. PubMed ID: 18698019
[TBL] [Abstract][Full Text] [Related]
20. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
